RecruitingNot ApplicableNCT04181684

LITT Followed by Hypofractionated RT for Recurrent Gliomas

Pilot Study of Laser Interstitial Thermal Therapy Followed By Hypofractionated Radiation Therapy for Treatment of Recurrent Gliomas.


Sponsor

University of Maryland, Baltimore

Enrollment

32 participants

Start Date

Jan 8, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to evaluate the treatment regimen of using Laser Interstitial Thermal Therapy (LITT) and Hypo-fractionated Radiation Therapy to treat patients with recurrent gliomas.


Eligibility

Min Age: 22 Years

Inclusion Criteria12

  • Patients with history of a WHO Grade II-IV glioma with radiographic evidence of recurrent or progressive tumor
  • Patient must have received prior radiation therapy for initial treatment of glioma
  • Patients with any number of recurrences are allowed as long as the patient has not undergone re-irradiation
  • Brain MRI with contrast demonstrates an enhancing tumor ≤ 6 cm in largest diameter within 60 days prior to registration
  • History and physical including neurological exam within 30 days prior to registration
  • Karnofsky performance status ≥ 60% within 30 days prior to registration
  • Age ≥ 22 years old
  • Minimum interval since completion of prior radiation treatment is 8 weeks
  • Patients will only receive re-irradiation if pathology from LITT is consistent with recurrent tumor
  • Patients must have signed an approved informed consent
  • Patients with the potential for pregnancy or impregnating their partner must agree to practice effective contraceptive methods to avoid conception while on study and for 6 months after study completion.
  • Female patients of child-bearing potential must have a negative pregnancy test within 28 days prior to study registration.

Exclusion Criteria7

  • Patients that are not surgical candidates for stereotactic biopsy or laser ablation
  • Patients with impaired cardiac function or clinically significant cardiac diseases, including any of the following:
  • History or presence of serious uncontrolled ventricular or significant arrhythmias.
  • Any of the following within 6 months prior to registration: myocardial infarction, severe/unstable angina, coronary artery bypass graft, congestive heart failure, cerebrovascular accident, transient ischemic attack , pulmonary embolism
  • Infratentorial tumor or evidence of leptomeningeal spread
  • Inability to undergo a MRI
  • Pregnant or breast-feeding women

Interventions

DEVICEProcedure: LITT

This procedure is done under MRI guidance and employs low-powered thermal energy to achieve tumor ablation through coagulation.

RADIATIONHypo-Fractionated Radiation Therapy

Treatments will be delivered once daily on consecutive treatment days (typically 5 fractions per week). Radiation therapy simulation is to be performed within 10 days of the LITT procedure.


Locations(4)

University of Maryland Greenebaum Cancer Center

Baltimore, Maryland, United States

UCH Kaufman Cancer Center

Bel Air, Maryland, United States

Central Maryland Radiation Oncology

Columbia, Maryland, United States

Baltimore Washington Medical Center

Glen Burnie, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04181684


Related Trials